Liquidtycoon.com
Stock Symbol: 		 
FREE NEWSLETTER SIGNUP - Email Address
Email:
Hemispherx BioPha (HEB)
at 4:00pm 0.25
-0.0055
Profile Overview
Quotes
Summary
Historical Prices

News & Info
Headlines
Financial Blogs

Company
Profile
Key Statistics
SEC Filings
Competitors

1d / 5d / 3m / 6m / 1y
Last Trade: 0.25
Trade Time: 4:00pm
Change: -0.0055 (-2.20%)
Prev Close: 0.2555
Open: 0.26
Bid: N/A
Ask: N/A
1yr Target Est: 1.50
Day's Range: 0.25 - 0.27
52wk Range: 0.17 - 0.55
Volume: 179,879
Avg Vol (3m): 238,186
Market Cap: 34.0M
P/E (ttm): N/A
EPS (ttm): 0.00
Div & Yield: N/A
Headlines
Hemispherx Biopharma Announces Financial Results for the Three Months Ended ...
MarketWatch (press release) (Monday 7th of May 2012 04:40:10 PM EDT)
Ampligen-FluMist nasal trial begins
FierceVaccines (Thursday 3rd of May 2012 10:08:32 AM EDT)
Hemispherx Biopharma Announces Test of Ampligen(R) With FluMist
MarketWatch (press release) (Monday 30th of April 2012 08:33:21 AM EDT)
Hemispherx Biopharma, Inc. Publishes Data On The Bioactivity Of Ampligen In Chronic Fatigue Syndrome (CFS)
Reuters Key Development (Monday 19th of March 2012 08:30:00 AM EDT)
Hemispherx Biopharma, Inc. Gains Regulatory Approval In Latin America
Reuters Key Development (Thursday 26th of January 2012 08:30:00 AM EST)
Hemispherx Biopharma, Inc. Receives U.S. Patent Office Notification Of Two New Patents Granted For Alferon LDO
Reuters Key Development (Tuesday 17th of January 2012 08:30:00 AM EST)
FDA Grants Hemispherx Biopharma, Inc. Extension In Pending New Drug Application For Treatment Of Chronic Fatigue Syndrome
Reuters Key Development (Wednesday 11th of January 2012 08:30:00 AM EST)
Hemispherx Biopharma, Inc. And Chronix Biomedical Present Data on a Novel Diagnostic Approach For CFS
Reuters Key Development (Monday 26th of September 2011 08:02:40 AM EDT)
Hemispherx Biopharma, Inc. Enters Into Strategic Alliance With Armada Health Care For Alferon N Injection
Reuters Key Development (Tuesday 6th of September 2011 08:31:00 AM EDT)
FDA Authorizes Clinical Trial Of Hemispherx Biopharma, Inc.'s Ampligen With Seasonal Influenza Vaccine
Reuters Key Development (Wednesday 20th of July 2011 08:02:00 AM EDT)
View more headlines »
The HOTTEST Stocks!
August 7th, 2009
The Most Active
Top Gaining
HOT STOCKS!
American International Group, Inc. (NYSE:AIG)
Bank of America Corporation (NYSE:BAC)
Citigroup Inc. (NYSE:C)
CIT Group Inc. (NYSE:CIT)
CBS Corporation (NYSE:CBS)
Stock Symbol:
Top News

Home | Top Financial News | Subscribe | Disclaimer | Privacy | About Us | Contact Us | Sitemap
© 2009 liquidtycoon.com